Oklo Inc. (NYSE:OKLO) Given Consensus Rating of "Moderate Buy" by Brokerages

Key Points

• Analysts remain cautiously bullish on Oklo, with 11 buys, one strong buy, 10 holds and one sell among 23 analysts, producing a “Moderate Buy” consensus and an average 12-month price target of $85.03.
• Oklo reported its first quarterly revenue of $1.21 million, far above expectations, but its quarterly loss widened to $48.5 million, or $0.28 per share, missing the $0.16 consensus estimate.
• Spending and execution risks are increasing: management raised 2026 operating cash-use guidance to $120 million–$150 million, while several analysts cut price targets and insiders sold roughly $29.9 million of shares over the past 90 days.

Oklo Inc. (NYSE:OKLO - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the twenty-three analysts that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, ten have given a hold recommendation, eleven have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $85.0312.

Several equities research analysts recently weighed in on the company. Citigroup decreased their price target on Oklo from $76.00 to $57.50 and set a "neutral" rating for the company in a report on Monday. Wolfe Research assumed coverage on shares of Oklo in a research note on Tuesday, May 19th. They issued a "peer perform" rating on the stock. HC Wainwright restated a "buy" rating and set a $90.00 price objective on shares of Oklo in a research report on Monday. Barclays reduced their target price on shares of Oklo from $82.00 to $76.00 and set an "overweight" rating for the company in a research note on Wednesday, July 22nd. Finally, UBS Group lowered their target price on shares of Oklo from $60.00 to $55.00 and set a "neutral" rating on the stock in a report on Thursday, June 11th.

Oklo News Roundup

Here are the key news stories impacting Oklo this week:

• Positive Sentiment: Oklo reported $1.21 million in second-quarter revenue, its first quarterly revenue and substantially above expectations. Revenue was supported in part by acquisition-related activity. OKLO Q2 Loss Widens Y/Y, Misses Estimates on Higher Costs
• Positive Sentiment: The Groves Isotope Test Reactor achieved first criticality less than a year after groundbreaking, providing evidence that Oklo can execute certain nuclear projects rapidly and advance its isotope-production plans. Oklo’s Groves Reactor Hits Criticality In Under a Year
• Positive Sentiment: HC Wainwright reaffirmed a Buy rating with a $90 price target, while Canaccord maintained Buy despite reducing its target from $125 to $100. These targets imply analysts still see substantial long-term upside.
• Neutral Sentiment: Oklo’s leadership refresh adds executives with experience at the Nuclear Regulatory Commission, National Grid and Joby Aviation as the company moves toward commercial production and deeper regulatory engagement. What Does Oklo Leadership Overhaul Mean As Commercialization Nears?
• Negative Sentiment: Second-quarter net loss widened to approximately $48.5 million, or $0.28 per share, missing the $0.16-per-share consensus estimate. Rising project-execution costs and accelerated development spending outweighed the revenue beat.
• Negative Sentiment: Management raised 2026 spending guidance, with operating cash use expected at $120 million to $150 million. First-half operating cash outflow was about $65.5 million and capital spending totaled roughly $126.9 million, reinforcing concerns about funding needs and execution risk. OKLO Q2 Earnings Call Links Higher Cash Use to Execution
• Negative Sentiment: Truist cut its price target from $55 to $51 and assigned a Hold rating. Other analysts also lowered forecasts after the earnings release, signaling near-term caution despite bullish longer-term targets.
• Negative Sentiment: Reported insider activity shows extensive selling and no purchases over the past six months, which may weigh on investor sentiment.

Oklo Stock Down 7.6%

Shares of Oklo stock opened at $44.74 on Tuesday. Oklo has a 52 week low of $36.61 and a 52 week high of $193.84. The firm's 50 day moving average is $50.43 and its two-hundred day moving average is $60.02. The firm has a market capitalization of $7.78 billion, a P/E ratio of -47.60 and a beta of 1.17.

Oklo (NYSE:OKLO - Get Free Report) last issued its quarterly earnings data on Friday, August 7th. The company reported ($0.28) earnings per share for the quarter, missing analysts' consensus estimates of ($0.16) by ($0.12). The business had revenue of $1.21 million during the quarter, compared to the consensus estimate of $0.09 million. During the same period in the prior year, the company posted ($0.18) EPS. The company's revenue was up 11900.0% compared to the same quarter last year. As a group, research analysts expect that Oklo will post -0.74 earnings per share for the current fiscal year.

Insider Transactions at Oklo

In other Oklo news, CFO Richard Craig Bealmear sold 73,081 shares of the company's stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $68.42, for a total transaction of $5,000,202.02. Following the transaction, the chief financial officer directly owned 397,642 shares in the company, valued at approximately $27,206,665.64. This represents a 15.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jacob Dewitte sold 140,000 shares of the company's stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $68.29, for a total value of $9,560,600.00. Following the completion of the sale, the chief executive officer owned 538,039 shares in the company, valued at approximately $36,742,683.31. This represents a 20.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 483,629 shares of company stock valued at $29,855,608 in the last ninety days. 12.70% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Oklo

Several institutional investors and hedge funds have recently modified their holdings of OKLO. Bank of New York Mellon Corp purchased a new position in shares of Oklo during the 2nd quarter worth $24,532,000. Handelsbanken Fonder AB grew its position in shares of Oklo by 43.8% in the second quarter. Handelsbanken Fonder AB now owns 52,900 shares of the company's stock valued at $2,768,000 after purchasing an additional 16,100 shares during the period. Hennion & Walsh Asset Management Inc. increased its stake in Oklo by 12.9% in the second quarter. Hennion & Walsh Asset Management Inc. now owns 36,609 shares of the company's stock valued at $1,916,000 after purchasing an additional 4,187 shares during the last quarter. Gradient Investments LLC increased its stake in Oklo by 38.6% in the second quarter. Gradient Investments LLC now owns 34,335 shares of the company's stock valued at $1,797,000 after purchasing an additional 9,570 shares during the last quarter. Finally, Evanson Financial LLC purchased a new position in Oklo during the second quarter worth about $232,000. Hedge funds and other institutional investors own 85.03% of the company's stock.

Oklo Company Profile

Oklo, Inc is a California-based energy technology company specializing in the design and development of advanced nuclear microreactors. Headquartered in Fremont, the firm focuses on small modular reactor (SMR) technology that leverages fast-neutron fission and liquid-metal cooling to deliver carbon-free power. Oklo’s core objective is to bring compact, factory-built reactors online within a decade, offering a low-footprint alternative to traditional large nuclear plants.

The company’s flagship product, the Aurora microreactor, is a 1.5-megawatt electric (MWe) fast reactor cooled by a sodium alloy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source